For example, semaglutide for weight loss (Wegovy) begins at 0.25 mg weekly, increasing every four weeks until reaching the maintenance dose of 2.4 mg, as outlined in the product's SmPC
These typically improve over time, especially with gradual dose escalation
The challenges come as an increasing number of Americans turn to the class of drugs, which were first used to help control blood sugar levels for diabetic patients about two decades ago
A clinical trial showed the average GLP-1 client loses between 10% and 15% of their body weight
Initially, the body compensates for this by enhancing insulin secretion leading to abnormally high concentrations of insulin in the blood, a condition called hyperinsulinemia
Due to its good spatial and temporal resolution and relative ease of recording, it is widely used as a biomarker of disease and as a tool to measure the brains activity to monitor the effectiveness of disease treatment [26]